学科与关键词
关键词
NSCLCLeptomeningeal MetastasesUncommon Mutation
- Osimertinib Leads the Way Toward Improving Outcomes of EGFR-Mutant NSCLC With Leptomeningeal MetastasesZheng, Mei-Mei; Li, Yang-Si; Sun, Hao; Wu, Yi-Long*Journal of Thoracic Oncology, 2021, 16(2): E12-E14.被引 1
- Midkine Dependent Immunosuppressive Environment in Cerebrospinal Fluid May Promote Leptomeningeal Metastases of EGFR mutant NSCLCLi, Y. -S.; Yin, K.; Lai, W. -P.; Zheng, M. -M.; Tu, H. -Y.; Wang, Z.; Zeng, L.; Jiang, B. -Y.; Yang, J. -J.; Zhou, Q.; Zhong, W. -Z.; Yang, X. -N.; Chen, H. -J.; Wu, Y. -L.
- Matched Targeted Therapy by cfDNA of CSF Beyond Leptomeningeal Metastases Progression Upon Osimertinib in EGFR-Mutated NSCLC PatientsZheng, M.; Li, Y.; Tu, H.; Sun, H.; Yin, K.; Yang, J.; Zhang, X.; Zhou, Q.; Wu, Y.
